Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model
- Author
- BORG, Sixten1 ; PERSSON, Ulf1 ; ALLIKMETS, Kristina2 ; ERICSSON, Karin2
[1] Swedish Institute for Health Economics, Lund, Sweden
[2] Nycomed Group, Roskilde, Denmark - Source
Clinical therapeutics. 2006, Vol 28, Num 11, pp 1947-1959, 13 p ; ref : 32 ref
- ISSN
- 0149-2918
- Scientific domain
- Pharmacology drugs
- Publisher
- Excerpta Medica, Belle Mead, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- anticoagulation cost-effectiveness percutaneous coronary intervention
- Keyword (fr)
- Analyse coût efficacité Angioplastie Anticoagulant Artère coronaire Bivalirudine Décision Economie santé Etude comparative Glycoprotéine IIbIIIa Homme Héparine Modèle Prise décision Récepteur biologique Thrombocyte Traitement instrumental Suède Antithrombine Enzyme Glycosaminoglycane Hydrolases Inhibiteur enzyme Peptidases Peptide Polypeptide Serine endopeptidases Thrombin Europe
- Keyword (en)
- Cost efficiency analysis Angioplasty Anticoagulant Coronary artery Bivalirudin Decision Health economy Comparative study Glycoprotein IIbIIIa Human Heparin Models Decision making Biological receptor Platelet Instrumentation therapy Sweden Antithrombin Enzyme Glycosaminoglycan Hydrolases Enzyme inhibitor Peptidases Peptides Polypeptide Serine endopeptidases Thrombin Europe
- Keyword (es)
- Análisis costo eficacia Angioplastia Anticoagulante Arteria coronaria Bivalirudina Decisión Economía salud Estudio comparativo Glicoproteína IIbIIIa Hombre Heparina Modelo Toma decision Receptor biológico Trombocito Tratamiento instrumental Suecia Antitrombina Enzima Glicosaminoglicano Hydrolases Inhibidor enzima Peptidases Péptido Polipéptido Serine endopeptidases Thrombin Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18409765
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.clinthera.2006.11.013 
https://dx.doi.org/10.1016/j.clinthera.2006.11.013
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1947\";s:8:\"\u0000*\u0000epage\";s:4:\"1959\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BORG\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Sixten\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"PERSSON, Ulf\";i:1;s:19:\"ALLIKMETS, Kristina\";i:2;s:15:\"ERICSSON, Karin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta Medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1947\";s:8:\"\u0000*\u0000epage\";s:4:\"1959\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BORG\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Sixten\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"PERSSON, Ulf\";i:1;s:19:\"ALLIKMETS, Kristina\";i:2;s:15:\"ERICSSON, Karin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta Medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1947\";s:8:\"\u0000*\u0000epage\";s:4:\"1959\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BORG\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Sixten\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"PERSSON, Ulf\";i:1;s:19:\"ALLIKMETS, Kristina\";i:2;s:15:\"ERICSSON, Karin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta Medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1947\";s:8:\"\u0000*\u0000epage\";s:4:\"1959\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BORG\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Sixten\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"PERSSON, Ulf\";i:1;s:19:\"ALLIKMETS, Kristina\";i:2;s:15:\"ERICSSON, Karin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta Medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2006.11.013\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"28\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1947\";s:8:\"\u0000*\u0000epage\";s:4:\"1959\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BORG\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Sixten\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:3:{i:0;s:12:\"PERSSON, Ulf\";i:1;s:19:\"ALLIKMETS, Kristina\";i:2;s:15:\"ERICSSON, Karin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:233:\"Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb\/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden : A decision-analytic model\";s:8:\"\u0000*\u0000place\";s:14:\"Belle Mead, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Excerpta Medica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
